# About MD NAD — Independent NAD+ Research Digest

> MD NAD is an independent editorial publisher summarizing the peer-reviewed clinical research on NAD+, NMN, NR, and IV infusion protocols. Not a clinic. Not a vendor.

## What MD NAD is

MD NAD is an independent editorial project that publishes summaries of the peer-reviewed research literature on NAD+ — nicotinamide adenine dinucleotide — including its precursors NMN and NR, its intravenous and injectable administration literature, and the mechanistic science underlying its role in aging, DNA repair, and cellular metabolism.

We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

Every quantitative claim on this site is cited to a specific peer-reviewed publication, with PubMed link or DOI. The citation list is on the references page.

## Why NAD+?

NAD+ is the compound with the largest active clinical trial footprint of any non-approved longevity compound as of 2026: more than 18 completed human RCTs for oral NMN and NR alone, plus IV infusion pilot studies, case series in addiction medicine, and emerging SC/IM injection trials.

MD NAD reads the primary literature and reports what the studies actually measured: effect sizes, doses, populations, and open questions. We do not cover GLP-1 compounds, peptides, or other unrelated research categories.

## What MD NAD is not

MD NAD is not a medical practice. We do not diagnose, treat, prevent, or cure any condition. We do not recommend dosing, routes of administration, or treatment protocols to any individual.

We are not a vendor. We do not sell NAD+, NMN, NR, or any related product. We have no affiliate relationships with supplement companies.

We are not a compounding pharmacy. We do not formulate, compound, or distribute any injectable or IV preparation.

If you are a patient or individual seeking guidance on NAD+ supplementation or IV therapy, you should consult a licensed healthcare provider.

---

Chrome-console readings of the peer-reviewed NAD+ record — clinical trials indexed, infusion rates logged, no prescriptions filled.